Updated

A study of more than 750,000 pregnancies reported on November 13, 2026, found early exposure to Ozempic, Wegovy and similar drugs was not linked to more pregnancy complications when used for weight loss. When prescribed for diabetes, however, the drugs were associated with a higher risk of premature birth, suggesting diabetes itself may drive the risk. Researchers cautioned that the drugs' safety during pregnancy remains uncertain.